Search Results - "Arcangeli, V"

Single-suture craniosynostosis: is there a correlation between preoperative ophthalmological, neuroradiological, and neurocognitive findings? by Chieffo, D. P. R., Arcangeli, V., Bianchi, F., Salerni, A., Massimi, L., Frassanito, P., Tamburrini, G.

“…Background In spite of literature data stating that children with single-suture craniosynostosis have an increased risk for neuropsychological deficits, no…”
Get full text

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy by Pignata, S, Califano, D, Lorusso, D, Arenare, L, Bartoletti, M, De Giorgi, U, Andreetta, C, Pisano, C, Scambia, G, Lombardi, D, Farolfi, A, Cinieri, S, Passarelli, A, Salutari, V, De Angelis, C, Mignogna, C, Priolo, D, Capoluongo, E D, Tamberi, S, Scaglione, G L, Arcangeli, V, De Cecio, R, Scognamiglio, G, Greco, F, Spina, A, Turinetto, M, Russo, D, Carbone, V, Casartelli, C, Schettino, C, Perrone, F

“…Immunotherapy combined with chemotherapy significantly improves progression-free survival (PFS) compared to first-line chemotherapy alone in advanced…”
Get more information

Intracranial complications of sinogenic and otogenic infections in children: an ESPN survey on their occurrence in the pre-COVID and post-COVID era by Massimi, L., Cinalli, G., Frassanito, P., Arcangeli, V., Auer, C., Baro, V., Bartoli, A., Bianchi, F., Dietvorst, S., Di Rocco, F., Gallo, P., Giordano, F., Hinojosa, J., Iglesias, S., Jecko, V., Kahilogullari, G., Knerlich-Lukoschus, F., Laera, R., Locatelli, D., Luglietto, D., Luzi, M., Messing-Jünger, M., Mura, R., Ragazzi, P., Riffaud, L., Roth, J., Sagarribay, A., Pinheiro, M. Santos, Spazzapan, P., Spennato, P., Syrmos, N., Talamonti, G., Valentini, L., Van Veelen, M. L., Zucchelli, M., Tamburrini, G.

“…Background COVID-19 pandemic is thought to have changed the epidemiology of some pediatric neurosurgical disease: among them are the intracranial complications…”
Get full text

Everolimus-exemestane (EE) vs palbociclib-letrozole (PL) or palbociclib-fulvestrant (PF) in the treatment of metastatic HR+, HER2- breast cancer. Indirect comparisons with network meta-analysis for daily clinical practice by Stocchi, L, Gianni, L, Nicolini, M, Santelmo, C, Carminati, O, Arcangeli, V, Papi, M, Cherubini, C, Polselli, A, Tassinari, D

Get full text

Preoperative neurocognitive evaluation as a predictor of brain tumor grading in pediatric patients with supratentorial hemispheric tumors by Chieffo, D., Tamburrini, Gianpiero, Frassanito, P., Arcangeli, V., Caldarelli, M., Di Rocco, C.

“…Objective The objective of the present study was to retrospectively evaluate the relationship between tumor grading and a selective evaluation of…”
Get full text

Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): old drugs, new results. The multicenter VICTOR-6 study by Cazzaniga, M, Orlando, L, Melegari, E, Arcangeli, V, Butera, A, Pinotti, G, Vallini, I, Mocerino, C, Giovanardi, F, Cretella, E, Gambaro, A, Pistelli, M, Donati, S, Pizzuti, L, Spagnuolo, A, Putzu, C, Leonardi, V, De Angelis, C, Pedroli, S, Torri, V

Get full text

2367 Second line treatments (slts) in metastatic, pre-treated gastric cancer. Pooled analysis of randomized clinical trials by Tassinari, D, Tamburini, E, Drudi, G, Venturini, B, Polselli, A, Arcangeli, V, Barzotti, E, Nicolini, M, Fabbri, P

Get full text

196 Innovative and hi-fidelity simulator for fascial plane blocks by Fusco, P, Petroni, GM, Tullj, S, Arcangeli, V, Balestra, G, Marinangeli, F

“…Background and AimsUltrasound guided regional anesthesia (UGRA) is an invasive procedure that involves complex motor skills.1 As ultrasound-guided regional…”
Get full text

Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer? by Tassinari, D., Arcangeli, V., Panzini, I., Sartori, S., Gianni, L., Ravaioli, A.

Get full text

Abstract P3-11-05: Everolimus-exemestane (EE) vs palbociclib-fulvestrant (PF) or abemaciclib-fulvestrant (AF) or everolimus-fulvestrant (EF) in the treatment of metastatic HR+, HER2- metastatic breast cancer and prior aromatase inhibitors treatment. An indirect comparison with network meta-analysis by Gianni, L, Arcangeli, V, Gianni, C, Stocchi, L, Menghini, L, Samorani, D, Ridolfi, C, Emiliano, T, Tassinari, D

“…Abstract Background. Treatment options for patients with hormone receptor positive metastatic breast cancer (MBC) and prior treatment with aromatase inhibitors…”
Get full text

Everolimus-exemestane (EE) vs palbociclib-letrozole (PL) or palbociclib-fulvestrant (PF) in the treatment of metastatic HR+, HER2- breast cancer. An indirect comparison with network meta-analysis by Cherubini, C., Gianni, L., Stocchi, L., Arcangeli, V., Carminati, O., Papi, M., Pasini, G., Fantini, M., Nicoletti, S.V.L., Tassinari, D.

Get full text

4P Mutational landscape of ovarian cancer patients (pts) by homologous recombination deficiency (HRD) status by Montanari, D., Zampiga, V., Cangini, I., Bandini, E., Casanova, C., Comerci, G., Arcangeli, V., Rosati, M., Rosati, F., Stefanetti, M., Burgio, S.L., Strada, I., Maniglio, P., Rossi, M., De Giorgi, U., Farolfi, A.

Get full text

53P Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients by Farolfi, A., Petracci, E., Gurioli, G., Tedaldi, G., Casanova, C., Arcangeli, V., Rosati, M., Burgio, S.L., Cursano, M.C., Lolli, C., Schepisi, G., De Giorgi, U.F.F.

Get full text

Treament options in advanced castration-resistant, prostate cancer (acrpc). preliminary results of a network meta-analysis by Bianchi, E., Cherubini, C., Nicoletti, S.L.V., Fantini, M., Drudi, F., Arcangeli, V., Santelmo, C., Montanari, F., Venturi, A., Stocchi, L., Tassinari, D.

Get full text

Toxicity of targeted therapy in elderly patients by Stocchi, L., Famtini, M., Drudi, G., Barzotti, E., Ridolfi, C., Nicoletti, S., Arcangeli, V., Drudi, F., Nicolini, M., Polselli, A., Santelmo, C., Tamburini, E., Gianni, L., Tassinari, D.

Get full text

Treatment of patients with metastatic colorectal cancer over 75 years: Rimini's monoinstitutional experience by Stocchi, L., Tamburini, E., Affatato, A., Fantini, M., Arcangeli, V., Polselli, A., Nicolini, M., Venturini, B., Drudi, G., Barzotti, E., Tassinari, D.

Get full text

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study by Cazzaniga, M.E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G.V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M.C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V., Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M.R., Vici, P., Zambelli, A., Clivio, L., Torri, V., Alù, M., Ancona, C., Andreis, D., Bajardi, E., Benedetto, C., Berardi, R., Bordin, E., Butti, C., Capri, G., Cicchiello, F., Cocciolone, V., Dester, M., D'Onofrio, L., Febbraro, A., Ferrarini, I., Fotia, V., Gervasi, E., Guaitoli, G., Licata, L., Liscia, N., Mentuccia, L., Miraglio, E., Nicolini, M., Paternò, E., Pedani, F., Pellegrini, D., Petrucelli, L., De Laurentiis, M., Pizzuti, L., Pogliani, C., Riva, F.

“…The BOLERO-2 trial reported efficacy and safety of Everolimus (EVE) and Exemestane (EXE) combination in HR+ advanced breast cancer (ABC) patients. The BALLET…”
Get full text

Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial by Tassinari, D, Drudi, G, Panzini, I, Pasini, G, Arcangeli, V, Fochessati, F, Gianni, L, Mianulli, A M, Oliverio, G, Pasquini, E, Sartori, S, Ravaioli, A

“…Some trials have suggested that the combination of gemcitabine and platinum compounds can have a synergistic effect on several solid tumors, but, at present,…”
Get full text

Modified ECF/wPELF in advanced gastric cancer. Results of a phase II trial by Fochessati, F., Tassinari, D., Arcangeli, V., Gianni, L., Papi, M., Polselli, A., Poggi, B., Fantini, M., Genestreti, G., Ravaioli, A.

“…Abstract only…”
Get full text

Modified ECF/wPELF in advanced gastric cancer. Results of a phase II trial by Fochessati, F., Tassinari, D., Arcangeli, V., Gianni, L., Papi, M., Polselli, A., Poggi, B., Fantini, M., Genestreti, G., Ravaioli, A.

“…Abstract only…”
Get full text